The effects of somatostatin on the proliferation of human HepG2 cells and the level of gene p16
10.3760/cma.j.issn.1006-9801.2010.11.013
- VernacularTitle:生长抑素抑制人类肝癌细胞株HepG2生长的机制及对p16基因表达水平的影响
- Author:
Junjun SU
;
Haoliang ZHAO
- Publication Type:Journal Article
- Keywords:
Somatostatin;
Genes,p16;
Cell cycle;
Liver neoplasms
- From:
Cancer Research and Clinic
2010;22(11):758-760
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effect of somatostatin on the Proliferation in Human HepG2 Cells and the Level of Gene p16. Methods The cell line HepG2 were divided into 3 groups: control groupA, low concentration group B and high concentration group C. The flow cytometry (FCM) was used to detect phase distribution of the cycles and detect the expression of p16 gene by using RT-PCR. Results Human HepG2 cells affected 24 hours later by different density SST, using FCM, we discovered that the G1 cell cycles of each A group, B group, C group occupied the proportion respectively is (51.41±3.27)%, (65.43±3.41)%, (69.02±3.75)%, that the S cell cycles is (36.86±2.31)%, (20.34±2.52)%, (18.50±3.09)%, that the G2 cell cycles is (11.46±1.96)%, (14.23±3.83)%, (12.48±3.18)%. Compare to the control groupA, the G1 cell cycles of groupB and group C were increased obviously. But the S cell cycles relatively reduced. The levels of p16 gene were expressed in each group detected by RT-PCR, but B group and C group expressed obviously. Conclusion The inhibited mechanism of somatostatin for HepG2 was expressed probably by improving levels of p16.